The ministry of health has announced 27 people are currently on oxygen after contracting coronavirus, as they receive treatment.
“This is the 360th national situation report since the confirmation of the first case of the coronavirus disease (COVID-19) in The Gambia, on the 16th March 2020.
Ten (10) new COVID-19-related deaths registered, bringing the total to 311 (Crude case-fatality ratio, 3.3%). The decedents’ age ranges from 54 – 90-year (6 males and 4 females) o Eight (8) had severe COVID-19 pneumonia and admitted in the COVID 19 treatment centres
“Four (4) of them, had diabetes mellitus, hypertension, severe anemia, Hepatic encephalopathy or Chronic bronchitis as a comorbidity. A total of 63 new cases were registered (cumulative cases, 9,533). The test positivity rate is 6.9% (63/907) of which MRCG tested 28 (7 positive) and NPHL 879 (56 positive) of the total new cases, 33 were males and 30 were females, with a median age of 34 years (Range: 1 – 80 years),” the ministry of health said in its situational report.
“Twenty-seven (27) cases are currently on oxygen therapy. For reasons of testing, 21 (33%) tested for travelling, 3 (5%) for suspicion of COVID-19, 5 (8%) wanted to know COVID 19 status, 2(3%) contact with a confirmed case, 2(3%) to determine COVID19 related deaths and 30(48%) for unspecified reasons. Five (5) cases were newly discharged from treatment centres, while 56 got discharged at least 10 days from the day they tested positive but evaded institutional isolation.
“Fifteen (15) new contacts were traced and monitored. As of 23rd August 2021, the following number of people have been with: o Janssen & Janssen: Only 1 dose:135,083 Sinopharm: Dose 1: 4,457 Dose 2: 595 o AstraZeneca: Dose 1: 31,254 Dose 2: 13,164. Cumulative number of AEFIs: 25 (23 non-serious and 2 serious). Of the total national target population (≥ 18 years) been vaccinated: o 9.5% are fully vaccinated (2 doses of AZ/Sinopharm or 1 dose of J&J) o 10.9% received at least one COVID-19 vaccine dose (AZ or J&J or Sinopharm),” it added.